![](/img/cover-not-exists.png)
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody
Nahimana, Aimable, Aubry, Dominique, Breton, Caroline S., Majjigapu, Somi R., Sordat, Bernard, Vogel, Pierre, Duchosal, Michel A.Volume:
55
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2013.869325
Date:
September, 2014
File:
PDF, 1.51 MB
english, 2014